Security key
75943R102
Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)
CUSIP: 75943R102
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 4,389,099
- Total 13F shares
- 163,415,012
- Share change
- +35,484,908
- Total reported value
- $1,156,675,796
- Put/Call ratio
- 49%
- Price per share
- $7.08
- Number of holders
- 193
- Value change
- +$253,277,512
- Number of buys
- 114
- Number of sells
- 70
Report period
Q3 2024
Institutions
193
Top holders
10
RLAY full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Relay Therapeutics, Inc. SEC filings
Relay Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75943R102
Recent filing periods:
Ownership snapshot
Top shareholders of RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
SB INVESTMENT ADVISERS (U...
13D/G signal
—
Evidence rows
50
Latest as of
30 Jun 2024
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD |
13F
Company
|
636%
|
$181,940,359
27,904,963 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
267%
|
$76,315,726
11,704,866 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
240%
|
$68,738,188
10,542,667 shares
|
— | 30 Jun 2024 |
| Casdin Capital, LLC |
13F
Company
|
192%
|
$55,084,702
8,448,574 shares
|
— | 30 Jun 2024 |
| Bellevue Group AG |
13F
Company
|
145%
|
$41,578,790
6,377,115 shares
|
— | 30 Jun 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
115%
|
$32,855,000
5,039,015 shares
|
— | 30 Jun 2024 |
| STATE STREET CORP |
13F
Company
|
97%
|
$27,699,607
4,248,406 shares
|
— | 30 Jun 2024 |
| JPMORGAN CHASE & CO |
13F
Company
|
90%
|
$25,841,376
3,963,401 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
193
Shares
163,415,012
Rows loaded
194
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
171
Q3 2024 holders
193
Holder diff
22
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend